
48.75 Delayed Data As of 3:39pm ET | ![]() Today’s Change | 40.38 Today|||52-Week Range 51.30 | -2.25% Year-to-Date |
Bank of Italy's Top 5 Buys of the 4th Quarter 1:00pm / GuruFocus News - Paid Partner Content | QIAGEN's (QGEN) New Launch to Enhance Clinical Lab Workflow Jan 24 / Zacks.com - Paid Partner Content |
Qiagen (QGEN) Expected to Beat Earnings Estimates: Can the Stock Move Higher? 10:01am / Zacks.com - Paid Partner Content |
Previous close | 48.82 |
Today’s open | 49.27 |
Day’s range | 48.44 - 48.86 |
Volume | 214,771 |
Average volume (3 months) | 976,702 |
Market cap | $11.2B |
Earnings growth (last year) | +42.99% |
Earnings growth (this year) | -13.13% |
Earnings growth (next 5 years) | +2.80% |
Revenue growth (last year) | +20.39% |
P/E ratio | 24.3 |
Price/Sales | 5.73 |
Price/Book | 3.61 |
Today’s change | Today’s % change | |
---|---|---|
BIOBio Rad Laboratories... | +0.99 | +0.21% |
BRKRBruker Corp | -0.52 | -0.74% |
PKIPerkinElmer Inc | +1.46 | +1.08% |
---- |
Next reporting date | February 8, 2023 |
EPS forecast (this quarter) | $0.47 |
Annual revenue (last year) | $2.3B |
Annual profit (last year) | $512.6M |
Net profit margin | 22.77% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Venlo, Limburg |